## **Core Concept**
Kawasaki disease is an acute, systemic vasculitis that primarily affects medium-sized arteries, with a predilection for the coronary arteries. It is the leading cause of acquired heart disease in children in developed countries. The treatment aims to reduce inflammation, prevent coronary artery complications, and manage symptoms.

## **Why the Correct Answer is Right**
The correct answer, **IV Immunoglobulin (IVIG)**, is the primary treatment for Kawasaki disease. IVIG, when administered early in the course of the disease, has been shown to reduce the risk of coronary artery aneurysms, which is a significant complication of Kawasaki disease. It works by modulating the immune response, although its exact mechanism in Kawasaki disease is not fully understood. **Aspirin** is also used in conjunction with IVIG for its anti-inflammatory effects and to help prevent coronary artery complications.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **Aspirin** is indeed used in the treatment of Kawasaki disease, it is not the sole treatment of choice. Aspirin is used for its anti-inflammatory effects and to help prevent thrombosis in the coronary arteries, but it does not replace the need for IVIG.
- **Option B:** **Steroids** are not typically the first-line treatment for Kawasaki disease. Their use is controversial and generally not recommended as an initial treatment due to potential adverse effects on the coronary arteries.
- **Option C:** There is no commonly recognized treatment for Kawasaki disease listed here that would be more appropriate than IVIG.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that early treatment with IVIG within the first 10 days of illness significantly reduces the risk of coronary artery aneurysms in Kawasaki disease. Delaying treatment beyond this window may still be beneficial but is less effective in preventing coronary complications.

## **Correct Answer:** . IV Immunoglobulin (IVIG)